Health & Fitness
Mon, March 19, 2012
LEXINGTON, Mass.--([ BUSINESS WIRE ])--[ Cubist Pharmaceuticals, Inc. ] (NASDAQ: CBST) today announced the official opening of its expanded research and development facility at its headquarters at 65 Hayden Avenue in Lexington, Massachusetts. The 104,000 square-foot expansion includes state-of-the art laboratory space for research and development around antibiotics and other acute care products, a molecular modeling room, office space, and conference rooms. Built to the LEED Silver Standard, the building features high efficiency plumbing and lighting fixtures, distribution controlled heating and cooling systems, and updated mechanical equipment and Energy Star-rated appliances.
"Innovative companies like Cubist Pharmaceuticals are on the leading edge of job creation in Massachusetts"
Cubist held an official opening ceremony for the R&D facility earlier today, with speakers including company President and CEO Michael Bonney and special guest U.S. Senator Scott Brown.
aAs we celebrate our 20th anniversary this year, it is our belief that this state-of-the-art R&D facility will be at the center of a wave of future growth and innovation for Cubist,a said Mr. Bonney. aWe look forward to many years of translating exciting science into real therapeutic options for patients in the acute care and hospital environment.a
aInnovative companies like Cubist Pharmaceuticals are on the leading edge of job creation in Massachusetts,a said Senator Brown. aMy priority in the Senate is to support job creators like Cubist in order to create more opportunities for hiring here in Massachusetts.a
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubistas web site at [ www.cubist.com ].
Photos/MultimediaGallery Available:[ http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50207204&lang=en ]